Menopause in patients with autoimmune diseases

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Sammaritano, Lisa R ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Autoimmunity; Menopause; Premature ovarian failure; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

ANDROGEN; CYCLOPHOSPHAMIDE; ESTROGEN; PROGESTERONE; SEX HORMONE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLIMACTERIUM; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; GIANT CELL ARTERITIS; HUMAN; IMMUNOSTIMULATION; MENOPAUSE; PREMATURE OVARIAN FAILURE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYCLOPHOSPHAMIDE; FEMALE; GONADAL STEROID HORMONES; HUMANS; MENOPAUSE; PERIMENOPAUSE; PRIMARY OVARIAN INSUFFICIENCY;

EID: 84858441431     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.006     Document Type: Review

References (62)

1. Lubo R.A. Menopause: endocrinology, consequences of estrogen deficiency, effects of hormone replacement therapy, treatment regimens. Comprehensive gynecology 2007, 1039-1071. Mosby Elsevier, Philadelphia. 5th Edition. V.L. Katz, G.M. Lentz, R.A. Lobo, D.M. Gershenson (Eds.).
2. Soules M.R., Sherman S., Parrott E., Rebar R., Santoro N., Utian W., et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001, 4(4):267-272.
3. de Bruin J.P., Bovenhuis H., van Noord P.A.H., Pearson P.L., van Arendonk J.A.M., Te Velde E.R., et al. The role of genetic factors in age at natural menopause. Hum Reprod 2001, 16:2014-2018.
4. Lund K.J. Menopause and the menopausal transition. Med Clin North Am 2008, 92:1253-1271.
5. Stokes J., Kannel W.B., Wolf P.A., Cupples L.A., D'Agostino R.B. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30years of follow-up in the Framingham Study. Circulation 1987, 75(6):V65-V73.
6. Johnell O. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos 2006, 17(12):1726-1733.
7. Bultink IEM, Lems WF, Kostense PJ, Dijkmans BAC, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005;527)2044-50.
8. Freeman E.W., Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007, 10(3):197-214.
9. Lobo R. Primary and secondary amenorrhea and precocious puberty: etiology, diagnostic evaluation, management. Comprehensive gynecology 2007, 933-961. Mosby Elsevier, Philadelphia. 5th Edition. V.L. Katz, G.M. Lentz, R.A. Lobo, D.M. Gershenson (Eds.).
10. Alper M., Garner P.R. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol 1985, 66:27-30.
11. Goswami D., Conway G.S. Premature ovarian failure. Hum Reprod Update 2005, 11(5):391-410.
12. Kauffman R.P., Castracane V.D. Premature ovarian failure associated with autoimmune polyglandular syndrome: pathophysiological mechanisms and future fertility. J Womens Health 2003, 12(5):513-520.
13. Mignot M.H., Schoemaker J., Kleingold M., Ramanath Rao B., Drexhage H.A. Premature ovarian failure. I: the association with autoimmunity. Eur J Obstet Gynecol Reprod Biol 1989, 30(1):59-66.
14. Chernyshov V.P., Radysh T.V., Gura I.V., Tatarchuk T.P., Khominskaya Z.B. Immune disorders in women with premature ovarian failure in the initial period. Am J Reprod Immunol 2001, 46(3):220-225.
15. Cervera R., Balasch J. Bidirectional effects on autoimmunity and reproduction. Hum Reprod Update 2008, 14(4):359-366.
16. Moncayo-Naveda H., Moncayo R., Benz R., Wolf A., Lauritzen C. Organ-specific antibodies against ovary in patients with systemic lupus erythematosus. Am J Obstet Gynecol 1989, 160(5):1227-1229.
17. Ethymiopoulou K., Aletras A.J., Ravazoula P., Niarakis A., Daoussis D., Antonopoulus I., et al. Antiovarian antibodies in primary Sjogren's syndrome. Rheumatol Int 2007, 27(12):1149-1155.
18. Pasoto S.G., Mendoca B.B., Bonfa E. Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 2002, 11:175-180.
19. Cooper G.S., Dooley M.A., Treadwell E.L., St.Claire W., Gilkeson G.S. Hormonal and reproductive risk factors for development of SLE: results of a population based case-control study. Arthritis Rheum 2002, 46(7):1830-1839.
20. Costenbader K.H., Feskanich D., Stampfer M.J., Kalson E.W. Reproductive and menopausal factors and risk of SLE in women. Arthritis Rheum 2007, 56(4):1251-1262.
21. Merlino, Cerhan J.R., Criswell L.A., Mikuls T.R., Saag K.G. Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin Arthritis Rheum 2003, 33(2):72-82.
22. Pikwer M, Bergstrom U, Nilsson J-A, Jacobsson L, Turesson C. Early menopause is a independent predictor of rheumatoid arthritis. Ann Rheum Disease. Published Online First: 4 October 2011. doi:10.1136/ard.2011.200059.
23. Mok C.C., Lau C.S., Wong R.W.S. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 1998, 41(5):831-837.
24. Katsifis G.E., Tzioufas A.G. Ovarian failure in systemic lupus erythematosus patients with pulsed intravenous cyclophosphamide. Lupus 2004, 13:673-678.
25. Boumpas D.T., Austin H.A., Vaughan E.M., Yarboro C.H., Klippel J.H., Balow J. Risk of sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulsed cyclophosphamide therapy. Ann Intern Med 1993, 119(5):366-369.
26. Ioannidis J.P., Katsifis G.E., Tzioufas A.G., Moutsopolous H.M. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol 2002, 29:2129-2135.
27. Yang X., Zhu X., Liang L., Zhan Z., Ye Y. Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Chin Med J 2005, 85(14):960-962.
28. Singh G., Saxena N., Aggarwal A., Misra R. Cytochrome P450 polymorphism as a predictor of ovarian toxicity to pulse cyclophosphamide in systemic lupus erythematosus. J Rheumatol 2007, 34(4):731-733.
29. Cutolo M., Capelino S., Sulli A., Serioli B., Secchi M., Villaggio B., et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci 2006, 1089:538-547.
30. Font J., Pallares L., Cervera R., Lopez-Soto A., Navarro M., Bosch X., et al. Systemic lupus onset in the elderly: clinical and immunological characteristics. Ann Rheum Dis 1991, 50:702-705.
31. Ho C.T.K., Mok C.C., Lau C.S., Wong R.W.S. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 1998, 57:437-440.
32. Boddaert J., Huong D.L.T., Amoura Z., Wechlser B., Godeau P., Piette J.C. Late onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 2004, 83(6):348-359.
33. Mok C.C., Lau C.S., Ho C.T., Wong R.W. Do flares of systemic lupus erythematosus decline after menopause?. Scand J Rheumatol 1999, 28(6):357-362.
34. Sanchez-Guerrero J., Villegas A., Mendoza-Fuentes A., Romero-Diaz J., Moreno-Coutino G., Cravioto M.C. Disease activity during the premenopausal and post menopausal periods in women with SLE. Am J Med 2001, 111(6):464-468.
35. Namjou B., Scofield R.H., Kelly J.A., Goodman E.L., Aberle T., Bruner G.R., Harley J.B. The effects of previous hysterectomy on lupus. Lupus 2009, 18:1000-1005.
36. Mok C.C., Wong R.W.S., Lau C.S. Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum 1999, 42(6):1274-1280.
37. Urowitz M.B., Ibanez D., Jerome D., Gladman D.D. The effect of menopause on disease activity in systemic lupus erythematosus. J Rheumatol 2006, 33:2192-2198.
38. Buyon J.P., Petri M., Kim M.Y., Kalunian K.C., Grossman J., Hahn B.H., et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005, 142:953-962.
39. Fernandez M., Calvo-Alen J., Alarcon G., Roseman J.M., Bastian H.M., Fessler B.J., et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXI. Disease activity, damage accrual and vascular events in pre- and post-menopausal women. Arthritis Rheum 2005, 52(6):1655-1664.
40. Gonzalez L.A., Pons-Estel G.J., Zhang J.S., McGwin G., Roseman J., Reveille J.D., et al. Effect of age, menopause and cyclophosphamide use on damage accrual in SLE patients from LUMINA, a multiethnic lupus cohort (LUMINA LXIII). Lupus 2009, 18:184-186.
41. Yazici Y., Paget S. Elderly onset rheumatoid arthritis. Rheum Dis Clin North Am 2000, 26(3):517-526.
42. Deal C.L., Meenan R.F., Goldenberg D.L., Anderson J.T., Sack B., Pastan R.S., et al. The clinical features of elderly-onset rheumatoid arthritis: a comparison with younger onset disease of similar duration. Arthritis Rheum 1985, 28(9):987-994.
43. Turkcapar N., Demir O., Atli T., Kopuk M., Turgay M., Kinikli G., et al. Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients. Arch Gerontol Geriatr 2006, 42(2):225-231.
44. Ostenson M., Aune B., Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983, 12(2):69-72.
45. Silman A., Kay A., Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992, 35(2):152-155.
46. Spector T.D., Roman E., Silman A.J. The pill, parity and rheumatoid arthritis. Arthritis Rheum 1990, 33(6):782-789.
47. Brun J.G., Nilssen S., Kvale G. Breastfeeding, other reproductive factors and rheumatoid arthritis. Rheumatology 1995, 34(6):542-546.
48. Pikwer M., Bergstrom U., Nilsson J.A., Jacobsson L., Berglund G., Turesson C. Breastfeeding but not use of oral contraceptives is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 2009, 68:526-530.
49. Karlson E.W., Mandl L.A., Hankinson S.E., Grodstein F. Do breastfeeding and other reproductive factors influence future risk of rheumatoid arthritis: results from the Nurses' Health Study. Arthritis Rheum 2004, 50(11):3458-3467.
50. Pikwer M, Bergstrom U, Nilsson J-A, Jacobsson L, Turesson C. Early menopause is a independent predictor of rheumatoid arthritis. Ann Rheum Disease. Published Online First: 4 October 2011. doi:10.1136/ard.2011.200059.
51. Forsblad D'Elia H, Larson A, Mattsson LA, Waltbrand E, Kvist G, Mellstrom D, et al. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. J Reumatol 2003;30:1456-63.
52. Walitt B., Pettinger M., Weinstein A., Katz J., Torner J., Wasko M.C., et al. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the Womens' Health Initiative randomized controlled trials. Arthritis Care Res 2008, 59(3):302-310.
53. Goemaere S., Ackerman C., Goethals K., DeKeyser F., Van de Straeten C., Verbruggen G., et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 1990, 17(12):1620-1622.
54. Olsson A.R., Skogh T., Wingren G. Aetiological factors of importance for the development of rheumatoid arthritis. Scand J Rheumatol 2004, 33(5):300-306.
55. Kuiper S.A., van Gestel A.M., Swinkels H.L., de Boo T.M., da Silva J.A.P., van Riel P.L.C.M. Influence of sex, age, and menopausal status on the course of early rheumatoid arthritis. J Rheumatol 2001, 28:1809-1816.
56. Sampaio-Barros P.D., Costa-Paiva L., Filardi S., Sachetto Z., Samara A.M., Marques-Neto J.F. Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 2005, 23(2):180-184.
57. Bhadauria S., Moser D.K., Clements P.J., Singh R.R., Lachenbruch P.A., Pitkin R.M., et al. Genital tract abnormalities and female sexual function impairment in systemic sclerosis. Am J Obstet Gynecol 1995, 172:580-587.
58. LaMontagna G., Vatti M., Valentini G., Tirri G. Osteopenia in systemic sclerosis: evidence of a participating role of earlier menopause. Clin Rheumatol 1991, 10(1):18-22.
59. Loucks J., Pope J.E. Osteoporosis in scleroderma. Semin Arthritis Rheum 2005, 34(4):678-682.
60. Scorza R., Caronni M., Bazzi S., Nador F., Beretta L., Antonioli R., et al. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci 2002, 966:238-246.
61. Beretta L., Caronni M., Origgi L., Ponti A., Santaniello A., Scorza R. Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheumatol 2006, 35(6):468-471.
62. Larsson K., Mellstrom D., Nordborg E., Oden A., Nordborg E. Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis. Ann Rheum Dis 2006, 65(4):529-532.